DIMENSIONAL FUND ADVISORS LP - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$18,484,169
+46.3%
687,911
+94.1%
0.01%
+50.0%
Q2 2023$12,637,726
+1858389.1%
354,395
+2014.7%
0.00%
Q4 2022$680
-99.9%
16,7590.0%0.00%
Q3 2022$554,000
-55.0%
16,759
-52.0%
0.00%
Q2 2022$1,230,000
-54.1%
34,943
-40.0%
0.00%
-100.0%
Q1 2022$2,677,000
-66.7%
58,219
-52.0%
0.00%
-50.0%
Q4 2021$8,043,000
-18.5%
121,289
-23.3%
0.00%
-33.3%
Q3 2021$9,870,000
-45.7%
158,090
-28.0%
0.00%
-50.0%
Q2 2021$18,184,000
+28.8%
219,588
+3.1%
0.01%
+20.0%
Q1 2021$14,122,000
-20.8%
213,076
-8.3%
0.01%
-16.7%
Q4 2020$17,826,000
+26.2%
232,300
-29.2%
0.01%0.0%
Q3 2020$14,125,000
+9.7%
328,015
+10.1%
0.01%0.0%
Q2 2020$12,871,000
+226.0%
298,058
+117.2%
0.01%
+200.0%
Q1 2020$3,948,000
-56.1%
137,233
-3.2%
0.00%
-33.3%
Q4 2019$8,990,000
+659.3%
141,697
+237.3%
0.00%
Q3 2019$1,184,000
+39.3%
42,010
-5.3%
0.00%
Q3 2018$850,000
+41.0%
44,3580.0%0.00%
Q2 2018$603,000
+88.4%
44,3580.0%0.00%
Q1 2018$320,000
+96.3%
44,3580.0%0.00%
Q4 2017$163,000
-15.1%
44,3580.0%0.00%
Q3 2017$192,000
+860.0%
44,358
+252.2%
0.00%
Q2 2017$20,000
-13.0%
12,5930.0%0.00%
Q1 2017$23,00012,5930.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders